DARE - Dare Bioscience - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DARE is currently covered by 2 analysts with an average price target of $6.38. This is a potential upside of $4.44 (228.87%) from yesterday's end of day stock price of $1.94.

Dare Bioscience's activity chart (see below) currently has 12 price targets and 20 ratings on display. The stock rating distribution of DARE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 251 days.

Highest price target for DARE is $12, Lowest price target is $8, average price target is $10.

Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 02-Dec-2025. First documented stock forecast 18-Aug-2016.

Currently out of the existing stock ratings of DARE, 3 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 18-Dec-2020

$12

$10.02 (506.06%)

$12

1 months 10 days ago
(02-Dec-2025)

0/6 (0%)

$10.28 (597.67%)

Buy

Since 04-Sep-2025

$8

$6.02 (304.04%)

4 months 8 days ago
(04-Sep-2025)

1/2 (50%)

$5.87 (275.59%)

660

Buy

Since 16-Aug-2024

$13

$11.02 (556.57%)

1 years 4 months 27 days ago
(16-Aug-2024)

0/1 (0%)

$9.43 (264.15%)

Buy

$3

$0.09 (3.09%)

1 years 7 months 29 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

Since 30-Aug-2023

$2

$0.02 (1.01%)

2 years 4 months 13 days ago
(30-Aug-2023)

1/1 (100%)

$-6.52 (-76.53%)

709

Show more analysts

Please expand the browser size to see the chart

What is DARE (Dare Bioscience) average time for price targets to be met?

On average it took 251 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on DARE (Dare Bioscience) with a proven track record?

KEMP DOLLIVER

Which analyst has the current lower performing score on DARE (Dare Bioscience) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on DARE (Dare Bioscience)?

Kemp Dolliver works at BROOKLINE and has 3 price targets and 2 ratings on DARE

Which analyst is the currently most bullish on DARE (Dare Bioscience)?

Debjit Chattopadhyay with highest potential upside - $70.02

Which analyst is the currently most reserved on DARE (Dare Bioscience)?

Zegbeh Jallah with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?